- Undergraduate Education
- B.A St. Louis University (1980)
- Graduate Education
- Ph.D. Washington University, St. Louis (1987)
- Postdoc. Washington University, St. Louis (1987-89)
- Professor. Albert Einstein College of Medicine
- Joined Texas A&M in 1996
Crystallography / Drug Design
My lab uses X-ray crystallography to better understand the relationship between proteins and ligands. Tiny differences in the structure of a molecule can radically change the interaction between a protein and ligand and we are only begining to understand how many factors play a role in this interaction. By manipulating the individual components of a compound it is possible to create a chemical that binds to the protein better than the natural substrate, and prevent the natural reaction from occurring. This is the basis for rational drug design. Our efforts have lead us to collaborations with other labs and scientists in many disciplines as our approach to directed compound design has applications not only in basic research but also in pesticide development, health research and clinical research.
Farhat, MR, Freschi, L, Calderon, R, Ioerger, T, Snyder, M, Meehan, CJ et al.. GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions. Nat Commun. 2019;10 (1):2128.
Crespo, RA, Dang, Q, Zhou, NE, Guthrie, LM, Snavely, TC, Dong, W et al.. Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase. J. Med. Chem. 2019;62 (9):4483-4499.
Dixit, A, Freschi, L, Vargas, R, Calderon, R, Sacchettini, J, Drobniewski, F et al.. Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting. Sci Rep. 2019;9 (1):5602.
Chen, Q, Shah, KN, Zhang, F, Salazar, AJ, Shah, PN, Li, R et al.. Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa. Mol. Pharm. 2019;16 (4):1606-1619.
Salazar, AJ, Sherekar, M, Tsai, J, Sacchettini, JC. R pyocin tail fiber structure reveals a receptor-binding domain with a lectin fold. PLoS ONE. 2019;14 (2):e0211432.
Ballinger, E, Mosior, J, Hartman, T, Burns-Huang, K, Gold, B, Morris, R et al.. Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition. Science. 2019;363 (6426):.
Miller, BK, Hughes, R, Ligon, LS, Rigel, NW, Malik, S, Anjuwon-Foster, BR et al.. Mycobacterium tuberculosis SatS is a chaperone for the SecA2 protein export pathway. Elife. 2019;8 :.
Xia, Y, Zhou, Y, Carter, DS, McNeil, MB, Choi, W, Halladay, J et al.. Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA. Life Sci Alliance. 2018;1 (3):e201800025.
Daniel-Wayman, S, Abate, G, Barber, DL, Bermudez, LE, Coler, RN, Cynamon, MH et al.. Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research. Am. J. Respir. Crit. Care Med. 2019;199 (8):947-951.
Rittershaus, ESC, Baek, SH, Krieger, IV, Nelson, SJ, Cheng, YS, Nambi, S et al.. A Lysine Acetyltransferase Contributes to the Metabolic Adaptation to Hypoxia in Mycobacterium tuberculosis. Cell Chem Biol. 2018;25 (12):1495-1505.e3.